DS
Digamber Sah
About Digamber Sah
Data last updated:
Digamber Sah is a Director at Amazeen Pharmaceuticals Private Limited (since 2015) and Director at Novitas Remedies Private Limited (since 2011). The companies operate in Chemicals and Trading. The largest current company by reported revenue is Amazeen Pharmaceuticals Private Limited at ₹1.03 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jun 2015 | 2015 | ₹1.03 Cr (FY 2024) | Active | |
| Director | 04 Jun 2011 | 2011 | Active |
Board colleagues of Digamber Sah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nagmani Kumar | 07148119 | Amazeen Pharmaceuticals Private Limited | Director |
| Mohd Meraj Uddin | 03525971 | Novitas Remedies Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Digamber Sah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Digamber Sah
Digamber Sah currently holds 2 directorships: Amazeen Pharmaceuticals Private Limited (Director, since 01 Jun 2015, revenue ₹1.03 Cr (FY 2024)); Novitas Remedies Private Limited (Director, since 04 Jun 2011).
Digamber Sah was first appointed on 04 Jun 2011 as Director at Novitas Remedies Private Limited. The most recent appointment on record is 01 Jun 2015 at Amazeen Pharmaceuticals Private Limited.
The current boards of Digamber Sah's companies include Nagmani Kumar (Amazeen Pharmaceuticals Private Limited), Mohd Meraj Uddin (Novitas Remedies Private Limited).